business.financialpost.com
Merus Labs stock tanks 16 per cent after acquisition
Merus Labs International Inc.’s stock sunk 16 per cent Tuesday following a $140 million deal to buy the cardiovascular drug portfolio of a Belgium speciality pharma company.The Toronto-based …